inositol has been researched along with Hypomenorrhea in 8 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effects of D-Chiro-Inositol in women affected by polycystic ovary syndrome (PCOS)." | 7.81 | Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol. ( Barbaro, L; Laganà, AS; Pizzo, A, 2015) |
| "Myo-inositol and D-chiro-inositol are capable of improving the ovarian function and metabolism of polycystic ovary syndrome (PCOS) patients." | 5.19 | Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS. ( Barbaro, L; Laganà, AS; Pizzo, A, 2014) |
| "The aim of this study was to compare the effectiveness of myo-inositol (MYO) and metformin, in monotherapy or in association with recombinant follicle stimulating hormone (r-FSH), in the treatment of menstrual irregularities, chronic anovulation, and female infertility in patients with polycystic ovary syndrome (PCOS)." | 5.14 | Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. ( Benedetto, V; Raffone, E; Rizzo, P, 2010) |
| "To evaluate the effects of D-Chiro-Inositol in women affected by polycystic ovary syndrome (PCOS)." | 3.81 | Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol. ( Barbaro, L; Laganà, AS; Pizzo, A, 2015) |
| "To evaluate the effects of the combination of d-chiro-inositol (DCI) and alpha lipoic acid on menses and metabolic disorders in women with polycystic ovary syndrome (PCOS)." | 3.81 | d-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS. ( Bartolo, M; Caruso, S; Cianci, A; Falduzzi, C; Fichera, M; Panella, M, 2015) |
| "Polycystic ovary syndrome is characterized by irregular cycles, hyperandrogenism, polycystic ovary at ultrasound and insulin resistance." | 1.42 | The menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective study. ( Cianci, A; Dondi, G; Grisendi, V; La Marca, A; Sighinolfi, G, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nas, K | 1 |
| Tűű, L | 1 |
| Pizzo, A | 3 |
| Laganà, AS | 3 |
| Barbaro, L | 2 |
| La Marca, A | 1 |
| Grisendi, V | 1 |
| Dondi, G | 1 |
| Sighinolfi, G | 1 |
| Cianci, A | 2 |
| Vitagliano, A | 1 |
| Quaranta, M | 1 |
| Noventa, M | 1 |
| Gizzo, S | 1 |
| Panella, M | 1 |
| Fichera, M | 1 |
| Falduzzi, C | 1 |
| Bartolo, M | 1 |
| Caruso, S | 1 |
| Raffone, E | 1 |
| Rizzo, P | 1 |
| Benedetto, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Inositols on Insulin Resistance in Children With Obesity (ONIRICO Trial)[NCT05701813] | 56 participants (Anticipated) | Interventional | 2023-02-01 | Not yet recruiting | |||
| [NCT01514942] | Phase 4 | 0 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for inositol and Hypomenorrhea
| Article | Year |
|---|---|
Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
Topics: Adolescent; Adult; Amenorrhea; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Follicl | 2014 |
Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.
Topics: Adult; Anovulation; Dietary Supplements; Drug Therapy, Combination; Female; Fertility Agents, Female | 2010 |
6 other studies available for inositol and Hypomenorrhea
| Article | Year |
|---|---|
A comparative study between myo-inositol and metformin in the treatment of insulin-resistant women.
Topics: Adult; Body Mass Index; Fasting; Female; Folic Acid; Humans; Inositol; Insulin; Insulin Resistance; | 2017 |
The menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective study.
Topics: Adult; Anti-Mullerian Hormone; Female; Humans; Inositol; Menstrual Cycle; Menstruation Disturbances; | 2015 |
Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol.
Topics: Adult; Blood Glucose; Female; Folic Acid; Follicle Stimulating Hormone; Humans; Inositol; Luteinizin | 2015 |
"Empiric" inositol supplementation in normal-weight non insulin resistant women with polycystic ovarian disease: from the absence of benefit to the potential adverse effects.
Topics: Female; Folic Acid; Humans; Inositol; Menstruation Disturbances; Ovary; Polycystic Ovary Syndrome; V | 2015 |
Authors' reply to: "Empiric" inositol supplementation in normal-weight non-insulin resistant women with polycystic ovarian disease: from the absence of benefit to the potential adverse effects.
Topics: Female; Folic Acid; Humans; Inositol; Menstruation Disturbances; Ovary; Polycystic Ovary Syndrome; V | 2015 |
d-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Inositol; Menstruation Disturbances; M | 2015 |